Common use of Instructions for Use Clause in Contracts

Instructions for Use. In all use of the trademark NASHA, QMS shall clearly indicate that NASHA is a trademark owned by Q-Med and in using the trademark follow the below instructions. • NASHA may only be used in direct conjunction with Deflux and Solesta. • In the use of NASHA, in conjunction with Deflux and Solesta, NASHA shall always have a clear function as the trademark for the technology and/or the gel that is manufactured using the technology, on which Deflux and Solesta are based. • NASHA may not be used separately or out of context. • Never indicate or imply that NASHA is an acronym or abbreviation of non-animal stabilized hyaluronic acid, or that it “means” stabilized non-animal hyaluronic acid. If NASHA needs to be “explained”, write: “NASHA™ is a patented technology for the production of stabilized non-animal hyaluronic acid” or equivalent. Always write: “stabilized non-animal hyaluronic acid” and not “non-animal stabilized hyaluronic acid”, in order to avoid the use of NASHA™ as an acronym/abbreviation. • Always write NASHA in uppercase letters. • NASHA with the affixed ® symbol may be used in countries where NASHA has been registered as a trademark. In all other countries, the ™ symbol shall be used, including countries where a trademark application is pending. Use ™ also for material intended for international use, if such use includes both countries in which NASHA is registered and countries where it is not. For status on trademark applications and registrations as of the [DATE], please see Exhibit [INSERT] to the [License Agreement]. • The first time NASHA is used on every page of a document or website, use either ™ or ® to alert the reader that NASHA is a trademark, like this: “NASHA™” or “NASHA®”. • All use of the NASHA trademark shall be accompanied by the wording “NASHATM/® , is a trademark licensed to QMS Therapeutics, Inc. by Q-Med AB (publ)”, somewhere in the same document.

Appears in 2 contracts

Sources: License Agreement (Salix Pharmaceuticals LTD), License Agreement (Salix Pharmaceuticals LTD)